logo
Share SHARE
FONT-SIZE Plus   Neg

GE Healthcare Reveals Phase 3 Results For Imaging Agent Flutemetamol

GE Healthcare, a unit of diversified conglomerate General Electric Co. (GE), Wednesday released results from four pooled brain biopsy studies and results from a brain autopsy study of the investigational PET amyloid imaging agent, flutemetamol.

The results revealed that both biopsy and autopsy study images had high sensitivity and specificity, and that strong concordance exists between flutemetamol PET images and Alzheimer's disease-associated beta amyloid brain pathology.

The data confirm the potential of flutemetamol as an imaging agent to detect beta amyloid plaque, a pathology associated with Alzheimer's disease in living patients.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
U.S. airlines collected a record $7.1 billion in revenue from fees for checked baggage and for changing or canceling reservations, reflecting a marked increase from 2010, according to a government report. The U.S. Government Accountability Office or GOA said in a report that U.S. airlines' revenue from these two fees increased to $7.1 billion in 2016 from $6.3 billion in 2010, in constant dollars. Ride-hailing company Uber's license to operate in London will not be renewed at the end of September, the transportation regulator in the UK capital said Friday. The move deals a huge blow to Uber and will impact more than 40,000 drivers using the company's app in London. Wal-Mart Stores Inc. is testing a new service that not only does a customer's grocery shopping and brings the items to his home, but even puts the grocery directly into the refrigerator. Walmart said it is partnering with August Home, a provider of smart locks and smart home accessories, to test the service in Silicon Valley.
comments powered by Disqus
Follow RTT